ENANTIOSELECTIVE SYNTHESIS OF BIOLOGICALLY IMPORTANT COMPOUNDS

Authors

David G. Evans, Brigham Young University
Dr. Matt A. Peterson, Brigham Young University

Keywords

enantioselective synthesis, compounds, pharmaceutical manufacturers

College

Life Sciences

Department

Biology

Abstract

Until only very recently it has been the common practice of most pharmaceutical manufacturers and manufacturers of agrochemicals such as herbicides and insecticides to market chiral compounds as mixtures of enantiomers. This practice has been driven by market forces due to the fact that it is much more cost efficient to market chiral compounds as mixtures rather than invest the resources needed to separate them. Tragic cases have shown that there is indeed a need for complete separation of enantiomers and their separate pre-clinical and clinical evaluation.

Recommended Citation

Evans, David G. and Peterson, Dr. Matt A. (2013) "ENANTIOSELECTIVE SYNTHESIS OF BIOLOGICALLY IMPORTANT COMPOUNDS," Journal of Undergraduate Research: Vol. 2013: Iss. 1, Article 1056.
Available at: https://scholarsarchive.byu.edu/jur/vol2013/iss1/1056